A PATIENT. AUNIQUE PROFILE. A PERSONALIZED THERAPY.
Personalized Immunotherapy, Powered by AI.
WHO WE ARE
Likang Life Sciences is a clinical-stage biotechnology company pioneering personalized cancer immunotherapies powered by AI and bioinformatics. We integrate neoantigen discovery with mRNA and cell therapy platforms to develop therapies tailored to each patient’s tumor.
LEARN MORE
LNEA
AI-Powered Neoantigen Discovery Platform
LK101
Personalized Neoantigen Vaccine
LK201
Personalized T-Cell Therapy
From One Profile To One Tailored Therapy
Every tumor is unique. Personalized immunotherapy begins with understanding its unique biology.
- PATIENT
- TUMOR SAMPLE
- GENE SEQUENCING
- AI NEOANTIGEN IDENTIFICATION
- PERSONALIZED THERAPY
- PATIENT
WHAT ARE NEOANTIGENS?
Neoantigens are tumor-specific protein fragments arising from mutations and absent from normal tissues.
Because they may be recognized as “non-self” by the immune system, they can serve as targets for personalized immunotherapy.
Every tumor is unique. Deeper insights into tumor biology and immunity are driving cancer immunotherapy toward greater precision and personalization.
History Of Immunology And Tumor Immunity
1893
Use of live bacteria and bacterial lysates to treat tumors-"Coley's Toxins" (William B. Coley).
Contact Us
Please get in touch using the form below, or feel free to contact us via email.